MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
65.07
+0.16
+0.25%
After Hours: 65.07 0 0.00% 16:11 07/08 EDT
OPEN
64.92
PREV CLOSE
64.91
HIGH
66.08
LOW
64.36
VOLUME
224.67K
TURNOVER
--
52 WEEK HIGH
77.00
52 WEEK LOW
52.50
MARKET CAP
1.41B
P/E (TTM)
-51.2564
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANIP last week (0630-0704)?
Weekly Report · 1d ago
Catalyst Watch: Amazon Prime Day, Delta earnings and stock-by-stock trade deal implications
Seeking Alpha · 4d ago
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
Barchart · 6d ago
Weekly Report: what happened at ANIP last week (0623-0627)?
Weekly Report · 06/30 11:17
Weekly Report: what happened at ANIP last week (0616-0620)?
Weekly Report · 06/23 11:09
Raymond James Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)
TipRanks · 06/20 12:06
Weekly Report: what happened at ANIP last week (0609-0613)?
Weekly Report · 06/16 11:16
ANI Pharmaceuticals presents preclinical data on Purified Cortrophin Gel use
TipRanks · 06/12 11:05
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.